VigiBase Search Services

VigiBase Search Services provide access to VigiBase, the World Health Organization's global database of adverse event reports for medicines and vaccines. Maintained by the Uppsala Monitoring Centre (UMC), VigiBase is the world's largest source of post-marketing safety data and covers approximately 99% of the world's population. It is used to identify and address medicine and vaccine safety issues at national and regional levels.

Access to VigiBase data is available free of charge to member organisations of the WHO Programme for International Drug Monitoring (WHO PIDM), whose contributions help build the database. For a fee, access is also available to marketing authorisation holders, software developers, research organisations, and universities.

Available Search Services

• VigiBase Custom Searches: Designed for obtaining specific data for analysis or studies. Data is updated twice weekly to provide the most current results.
• VigiBase Extract: Provides aggregated and regularly updated case-level data, available on request.
• VigiAccess: An open-access website offering limited statistical data from VigiBase. The type and level of data available is defined by the platform's scope.
• VigiAccess API: A documented API that allows software developers to integrate VigiAccess search functionality directly into their own software applications.

Key Characteristics of VigiBase

• Recognised as the world's largest post-marketing safety database for medicines and vaccines.
• Populated through contributions from WHO PIDM member organisations globally.
• Supports safety signal identification at both national and regional levels.
• Data updated on a regular basis, with Custom Searches refreshed twice weekly.

VigiBase Search Services are suited to a range of use cases including pharmacovigilance research, regulatory review, and software development. The availability of both a direct data extract service and a developer-facing API supports integration into existing workflows and platforms.